Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 2
1998 1
1999 3
2000 3
2001 4
2002 1
2003 2
2004 2
2005 2
2013 2
2014 2
2016 2
2017 4
2018 4
2019 4
2020 3
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Results by year
Filters applied: . Clear all
Page 1
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. Among authors: gulmans v. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
Jung A, Orenti A, Dunlevy F, Aleksejeva E, Bakkeheim E, Bobrovnichy V, Carr SB, Colombo C, Corvol H, Cosgriff R, Daneau G, Dogru D, Drevinek P, Vukic AD, Fajac I, Fox A, Fustik S, Gulmans V, Harutyunyan S, Hatziagorou E, Kasmi I, Kayserová H, Kondratyeva E, Krivec U, Makukh H, Malakauskas K, McKone EF, Mei-Zahav M, de Monestrol I, Olesen HV, Padoan R, Parulava T, Pastor-Vivero MD, Pereira L, Petrova G, Pfleger A, Pop L, van Rens JG, Rodic M, Schlesser M, Storms V, Turcu O, Woz Niacki L, Yiallouros P, Zolin A, Downey DG, Naehrlich L. Jung A, et al. Among authors: gulmans v. ERJ Open Res. 2021 Dec 27;7(4):00411-2021. doi: 10.1183/23120541.00411-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34984210 Free PMC article.
Paediatric rehabilitation.
Helders PJ, Engelbert RH, Gulmans VA, van der Net J. Helders PJ, et al. Among authors: gulmans va. Disabil Rehabil. 2001 Jul 20;23(11):497-500. doi: 10.1080/09638280010029840. Disabil Rehabil. 2001. PMID: 11437202
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Carr SB, Cosgriff R, Harutyunyan S, Middleton PG, Ruseckaite R, Ahern S, Daneau G, Filho LVRFDS, Stephenson AL, Cheng SY, Melo J, Corvol H, Burgel PR, Nährlich L, McKone E, Colombo C, Salvatore M, Padoan R, Abdrakhmanov O, Gulmans V, Byrnes CA, Amelina E, Kondratyeva E, Zhekayte E, Kashirskaya N, Zampoli M, Pastor-Vivero MD, Mondejar-Lopez P, de Monestrol I, Jung A, McClenaghan E, Brownlee K, Rizvi S, Goss CH, Elbert A, Faro A, Gutierrez H, Marshall BC. Carr SB, et al. Among authors: gulmans v. J Cyst Fibros. 2021 Jul;20(4):715-716. doi: 10.1016/j.jcf.2021.03.028. Epub 2021 Apr 15. J Cyst Fibros. 2021. PMID: 33941502 Free PMC article. No abstract available.
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB; Global Registry Harmonization Group. Cosgriff R, et al. Among authors: gulmans v. J Cyst Fibros. 2020 May;19(3):355-358. doi: 10.1016/j.jcf.2020.04.012. Epub 2020 Apr 25. J Cyst Fibros. 2020. PMID: 32376098 Free PMC article.
Long-term effectiveness of dual CFTR modulator treatment of cystic fibrosis.
Muilwijk D, Zomer-van Ommen DD, Gulmans VAM, Eijkemans MJC, van der Ent CK; Dutch Cystic Fibrosis Registry (NCFR) Steering Group:. Muilwijk D, et al. Among authors: gulmans vam. ERJ Open Res. 2022 Nov 14;8(4):00204-2022. doi: 10.1183/23120541.00204-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36382237 Free PMC article.
Risk factors for lung disease progression in children with cystic fibrosis.
van Horck M, van de Kant K, Winkens B, Wesseling G, Gulmans V, Hendriks H, van der Grinten C, Jöbsis Q, Dompeling E. van Horck M, et al. Among authors: gulmans v. Eur Respir J. 2018 Jun 7;51(6):1702509. doi: 10.1183/13993003.02509-2017. Print 2018 Jun. Eur Respir J. 2018. PMID: 29773689 Free article.
41 results